Page last updated: 2024-12-06
3-methoxybenzonitrile
Description
3-methoxybenzonitrile is an organic compound with the formula CH3OC6H4CN. It is a white solid that is soluble in organic solvents. 3-methoxybenzonitrile is used as an intermediate in the synthesis of pharmaceuticals and other fine chemicals. It can be synthesized by the reaction of 3-methoxyphenol with cyanogen bromide. 3-methoxybenzonitrile has been shown to exhibit a variety of biological activities, including antimicrobial, anti-inflammatory, and antioxidant effects. It is also a promising candidate for the development of new anticancer drugs. 3-methoxybenzonitrile is being studied for its potential use in a variety of applications, including the treatment of bacterial infections, inflammatory diseases, and cancer. It is also being investigated for its potential to enhance the performance of solar cells and other energy storage devices.'
3-methoxybenzonitrile: RN & N1 from 9th CI Form Index; RN given refers to unlabeled parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|
| PubMed CID | 73712 |
| SCHEMBL ID | 103841 |
| MeSH ID | M0090271 |
Synonyms (40)
| Synonym |
|---|
| EN300-16193 |
| STL354589 |
| nsc-225049 |
| m-anisonitrile |
| benzonitrile, m-methoxy- |
| m-methoxybenzonitrile |
| 3-methoxybenzonitrile |
| nsc225049 |
| 1527-89-5 |
| m-cyanoanisole |
| benzonitrile, 3-methoxy- |
| m-methoxybenzontrile |
| inchi=1/c8h7no/c1-10-8-4-2-3-7(5-8)6-9/h2-5h,1h |
| 3-methoxybenzonitrile, 98% |
| AKOS000198127 |
| M1291 |
| 3-cyanoanisole |
| HMS1725P03 |
| m-methoxybenzonitrile;benzonitrile, 3-methoxy-;benzonitrile, m-methoxy- |
| A21196 |
| 3-anisonitrile |
| 3-cyano-anisole |
| uy5e89bbs6 , |
| nsc 225049 |
| unii-uy5e89bbs6 |
| einecs 216-201-3 |
| FT-0615990 |
| AB00159 |
| CS-M0746 |
| SCHEMBL103841 |
| PS-5266 |
| 5-methoxybenzonitrile |
| 3-methoxy benzonitrile |
| AM86650 |
| STR02155 |
| AC-24362 |
| DTXSID4074695 |
| J-512785 |
| mfcd00001801 |
| Z54464103 |
Research
Studies (5)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 29.80
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| Metric | This Compound (vs All) |
|---|
| Research Demand Index | 29.80 (24.57) | | Research Supply Index | 1.79 (2.92) | | Research Growth Index | 4.55 (4.65) | | Search Engine Demand Index | 28.68 (26.88) | | Search Engine Supply Index | 2.00 (0.95) |
| |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |